DLocal Limited (DLO) details closing of secondary share offering in Form 6-K
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
DLocal Limited, a foreign private issuer based in Montevideo, Uruguay, submitted a Form 6-K for September 2025. The report mainly furnishes a press release dated September 5, 2025, announcing the closing of a secondary offering. The filing is signed by Interim Chief Financial Officer Jeffrey Brown on behalf of the company.
Positive
- None.
Negative
- None.
FAQ
What did DLocal Limited (DLO) report in its September 2025 Form 6-K?
DLocal Limited filed a Form 6-K for September 2025 to furnish a press release. The exhibit, dated September 5, 2025, announces the closing of a secondary offering by the company. The report is a disclosure by this foreign private issuer.
What is the key exhibit in DLocal Limited (DLO)'s September 2025 Form 6-K?
The key exhibit is a press release identified as Exhibit 99.1. It is dated September 5, 2025 and titled “DLocal Limited Announces Closing of Secondary Offering,” indicating that the document focuses on completion of a secondary share transaction.
Who signed the September 2025 Form 6-K for DLocal Limited (DLO)?
The Form 6-K was signed on behalf of DLocal Limited by Jeffrey Brown. He is identified in the document as the Interim Chief Financial Officer, serving as the authorized officer executing the report under the Securities Exchange Act of 1934.
When is DLocal Limited (DLO)'s secondary offering press release dated?
The secondary offering press release attached to the Form 6-K is dated September 5, 2025. This date appears in the exhibit index description, which identifies the document as announcing the closing of a secondary offering for DLocal Limited.
Where is DLocal Limited (DLO) headquartered according to the Form 6-K?
DLocal Limited lists its principal executive office at Dr. Luis Bonavita 1294, Montevideo, Uruguay 11300. The filing also provides a contact telephone number of +1 (424) 392-7437, identifying the company’s main business address for regulatory purposes.